| | (S)-7,7Bis[(4S)-(phenyl)oxazol-2-yl)]-2,23,3tetrahydro-1,1spirobiindane, min. 97% (Sa,S,S)-SpiroBOX|(S)-7,7雙[(4S)-(苯基)惡唑-2-基)-2,2,3,3-四氫-1,1,6,6'-二醇 基本信息 更多信息 |
| 中文名稱: | (S)-7,7雙[(4S)-(苯基)惡唑-2-基)-2,2,3,3-四氫-1,1,6,6'-二醇 | | 中文同義詞: | (S)-7,7雙[(4S)-(苯基)惡唑-2-基)-2,2,3,3-四氫-1,1,6,6'-二醇 10G;(S)-7,7雙[(4S)-(苯基)惡唑-2-基)-2,2,3,3-四氫-1,1,6,6'-二醇;(4S,4'S)-2,2'-[(1S)-2,2',3,3'-四氫-1,1'-螺二[1H-茚]-7,7'-二基]雙[4,5-二氫-4-苯基惡唑 | | 英文名稱: | (S)-7,7Bis[(4S)-(phenyl)oxazol-2-yl)]-2,23,3tetrahydro-1,1spirobiindane, min. 97% (Sa,S,S)-SpiroBOX | | 英文同義詞: | (S)-7,7Bis[(4S)-(phenyl)oxazol-2-yl)]-2,23,3tetrahydro-1,1spirobiindane, min. 97% (Sa,S,S)-SpiroBOX;(SA,S,S)-SPIROBOX;(4S,4'S)-2,2'-[(1S)-2,2',3,3'-TETRAHYDRO-1,1'-SPIROBI[1H-INDENE]-7,7'-DIYL]BIS[4,5-DIHYDRO-4-PHENYLOXAZOLE];(R)-7-(4,5-Dihydrooxazol-2-yl)-7′-di(3,5-ditertbutylphenyl)phosphino-1,1′-spirobiinane;Oxazole,2,2'-[(1S)-2,2',3,3'-tetrahydro-1,1'-spirobi[1H-indene]-7,7'-diyl]bis[4,5-dihydro-4-phenyl-,(4S,4'S)-;(Sa,S,S)-7,7′-bis(4′-phenyloxazol-2-yl)-1,1′-spirobiindane;(S)-7,7-Bis[(4S)-(phenyl)oxazol-2-yl)]-2,2,3,3-tetrahydro-1,1-spirobiindane | | CAS號: | 940880-69-3 | | 分子式: | C35H30N2O2 | | 分子量: | 510.62 | | EINECS號: | | ![(S)-7,7Bis[(4S)-(phenyl)oxazol-2-yl)]-2,23,3tetrahydro-1,1spirobiindane, min. 97% (Sa,S,S)-SpiroBOX|(S)-7,7雙[(4S)-(苯基)惡唑-2-基)-2,2,3,3-四氫-1,1,6,6'-二醇](/CAS/20150408/GIF/940880-69-3.gif) |
|
| 按國家瀏覽(S)-7,7Bis[(4S)-(phenyl)oxazol-2-yl)]-2,23,3tetrahydro-1,1spirobiindane, min. 97% (Sa,S,S)-SpiroBOX國外供應商 |
中國供應商 |
|
(S)-7,7Bis[(4S)-(phenyl)oxazol-2-yl)]-2,23,3tetrahydro-1,1spirobiindane, min. 97% (Sa,S,S)-SpiroBOX 推薦供應商 |
|
|
建議您優(yōu)先選擇企業(yè)會員,我們對企業(yè)會員產品有嚴格審核。 |
|
1
|